S. Rudisile

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

G. Böning, C. Auernhammer, C. Spitzweg, 2019, BMC Cancer.

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

G. Böning, C. Auernhammer, C. Spitzweg, 2019, BMC Cancer.